Video: Easyhaler® in action
Product info | 18/06/2020Prescribing information available here and Adverse Event Reporting information can be found at the bottom of the page
The internal resistance of Easyhaler® allows consistent dose delivery, even for patients with low inhalation flow.1
References:
- Haikarainen J, et al. Pulm Ther 2017;3(1):125-38.
Date of preparation: March 2024 / EASYH-1768(2)
Bufomix (budesonide/formoterol) Easyhaler Contraindications and Undesirable effects
Contraindications:
Hypersensitivity to the active substances or lactose monohydrate (which contains small amounts of milk protein).
Undesirable effects:
Common (≥1/100 to < 1/10): Candida infections in the oropharynx, pneumonia (in COPD patients) headache, tremor, palpitations, mild irritation in the throat, coughing, dysphonia including hoarseness.
See SmPC for full list of adverse reactions
| Adverse effects should be reported. You can report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or by email on medsafety@hpra.ie. Adverse effects should also be reported to Orion Pharma via ie.medicalinformation@orionpharma.com |
Was this article useful?
DATE OF PREPARATION: APRIL 2025/EASYH-688(11)
FULL PRESCRIBING INFORMATION AVAILABLE HERE
For more information about Orion and Sustainability click here
| Adverse effects should be reported. You can report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie or by email on medsafety@hpra.ie. Adverse effects should also be reported to Orion Pharma via ie.medicalinformation@orionpharma.com |
